Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma

NCT03376737 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Lung Adenocarcinoma

Interventions

DRUG: Apatinib

Sponsor

Henan Cancer Hospital

Collaborators

[object Object]